Global Liposomal Formulation Development Service Supply, Demand and Key Producers, 2026-2032
The global Liposomal Formulation Development Service market size is expected to reach $ 1267 million by 2032, rising at a market growth of 12.0% CAGR during the forecast period (2026-2032).
Liposomal Formulation Development Service refers to a specialized pharmaceutical development service that focuses on designing, optimizing, and producing liposome-based drug delivery systems. These services typically include lipid selection, formulation design, encapsulation of active pharmaceutical ingredients (APIs), characterization (e.g., size, zeta potential, encapsulation efficiency), stability studies, scale-up, and technology transfer. Liposomal formulations enhance drug bioavailability, control release profiles, reduce toxicity, and improve targeting, making them widely used in oncology, vaccines, anti-infectives, and gene therapies.The average gross profit margin of this product is 35%.
The global market for liposomal formulation development is experiencing strong momentum, primarily fueled by the commercialization of mRNA vaccines, expansion of RNA-based therapeutic pipelines, and rising demand for long-acting drug delivery systems. The COVID-19 pandemic served as a catalyst, accelerating both investment and infrastructure buildup in lipid-based delivery technologies.
A notable trend is the shift from fragmented service offerings to fully integrated solutions, where clients seek partners who can deliver not only formulation design but also lipid raw materials, process scale-up, analytical method development, GMP manufacturing, and regulatory support. Leading CDMOs like Evonik, Polymun Scientific, and Corden Pharma have expanded capabilities through acquisition and facility upgrades, particularly in aseptic fill-finish and lipid excipient production.
In the raw materials space, high-purity synthetic lipids remain a high-barrier segment, dominated by players such as Nippon Fine Chemical and Croda (via Avanti Polar Lipids). These companies maintain IP-secured production processes and cater primarily to North American and European innovators. While emerging suppliers in China and India are entering the market, they face challenges in GMP compliance, analytical robustness, and IP clearance.
On the application side, liposomes have evolved from classical cancer and vaccine applications to now include siRNA, mRNA, and CRISPR therapies. This has prompted a wave of innovation in ionizable lipid design and formulation optimization. Clients are increasingly looking for service providers capable of custom lipid synthesis aligned with delivery goals, aiming to improve drug efficacy and batch-to-batch consistency.
Looking forward, the liposomal formulation market is expected to maintain double-digit growth over the next 3?5 years. The sector is becoming increasingly IP-driven and quality-intensive, with successful players needing to demonstrate expertise across formulation science, process engineering, lipid chemistry, and regulatory compliance. The continued approval of nucleic acid therapeutics will reinforce demand for specialized CDMOs and lipid excipient suppliers with deep technical foundations.
This report studies the global Liposomal Formulation Development Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Liposomal Formulation Development Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liposomal Formulation Development Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Liposomal Formulation Development Service total market, 2021-2032, (USD Million)
Global Liposomal Formulation Development Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Liposomal Formulation Development Service total market, key domestic companies, and share, (USD Million)
Global Liposomal Formulation Development Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global Liposomal Formulation Development Service total market by Type, CAGR, 2021-2032, (USD Million)
Global Liposomal Formulation Development Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Liposomal Formulation Development Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cytiva, Croda International, Evonik, Merck KGaA, Genevant Sciences, Nippon Fine Chemical, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Liposomal Formulation Development Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Liposomal Formulation Development Service Market, By Region:
1. How big is the global Liposomal Formulation Development Service market?
2. What is the demand of the global Liposomal Formulation Development Service market?
3. What is the year over year growth of the global Liposomal Formulation Development Service market?
4. What is the total value of the global Liposomal Formulation Development Service market?
5. Who are the Major Players in the global Liposomal Formulation Development Service market?
6. What are the growth factors driving the market demand?
Liposomal Formulation Development Service refers to a specialized pharmaceutical development service that focuses on designing, optimizing, and producing liposome-based drug delivery systems. These services typically include lipid selection, formulation design, encapsulation of active pharmaceutical ingredients (APIs), characterization (e.g., size, zeta potential, encapsulation efficiency), stability studies, scale-up, and technology transfer. Liposomal formulations enhance drug bioavailability, control release profiles, reduce toxicity, and improve targeting, making them widely used in oncology, vaccines, anti-infectives, and gene therapies.The average gross profit margin of this product is 35%.
The global market for liposomal formulation development is experiencing strong momentum, primarily fueled by the commercialization of mRNA vaccines, expansion of RNA-based therapeutic pipelines, and rising demand for long-acting drug delivery systems. The COVID-19 pandemic served as a catalyst, accelerating both investment and infrastructure buildup in lipid-based delivery technologies.
A notable trend is the shift from fragmented service offerings to fully integrated solutions, where clients seek partners who can deliver not only formulation design but also lipid raw materials, process scale-up, analytical method development, GMP manufacturing, and regulatory support. Leading CDMOs like Evonik, Polymun Scientific, and Corden Pharma have expanded capabilities through acquisition and facility upgrades, particularly in aseptic fill-finish and lipid excipient production.
In the raw materials space, high-purity synthetic lipids remain a high-barrier segment, dominated by players such as Nippon Fine Chemical and Croda (via Avanti Polar Lipids). These companies maintain IP-secured production processes and cater primarily to North American and European innovators. While emerging suppliers in China and India are entering the market, they face challenges in GMP compliance, analytical robustness, and IP clearance.
On the application side, liposomes have evolved from classical cancer and vaccine applications to now include siRNA, mRNA, and CRISPR therapies. This has prompted a wave of innovation in ionizable lipid design and formulation optimization. Clients are increasingly looking for service providers capable of custom lipid synthesis aligned with delivery goals, aiming to improve drug efficacy and batch-to-batch consistency.
Looking forward, the liposomal formulation market is expected to maintain double-digit growth over the next 3?5 years. The sector is becoming increasingly IP-driven and quality-intensive, with successful players needing to demonstrate expertise across formulation science, process engineering, lipid chemistry, and regulatory compliance. The continued approval of nucleic acid therapeutics will reinforce demand for specialized CDMOs and lipid excipient suppliers with deep technical foundations.
This report studies the global Liposomal Formulation Development Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Liposomal Formulation Development Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liposomal Formulation Development Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Liposomal Formulation Development Service total market, 2021-2032, (USD Million)
Global Liposomal Formulation Development Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Liposomal Formulation Development Service total market, key domestic companies, and share, (USD Million)
Global Liposomal Formulation Development Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global Liposomal Formulation Development Service total market by Type, CAGR, 2021-2032, (USD Million)
Global Liposomal Formulation Development Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Liposomal Formulation Development Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cytiva, Croda International, Evonik, Merck KGaA, Genevant Sciences, Nippon Fine Chemical, Polymun Scientific, Corden Pharma, Acuitas Therapeutics, Creative Biolabs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Liposomal Formulation Development Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Liposomal Formulation Development Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- mRNA-Liposomal
- siRNA-Liposomal
- Other
- Pre-formulation Development
- Formulation Screening and Optimization
- Analytical Method Development
- Process Development
- Other
- Small Molecule Drugs
- Peptides and Proteins
- Nucleic Acid Therapeutics
- Others
- Gene Therapy
- Vaccine
- Cancer Treatment
- Others
- Cytiva
- Croda International
- Evonik
- Merck KGaA
- Genevant Sciences
- Nippon Fine Chemical
- Polymun Scientific
- Corden Pharma
- Acuitas Therapeutics
- Creative Biolabs
- GenScript
- WuXi STA
- MicroNano Biologics
- Precigenome
- Catalent
- Wacker
1. How big is the global Liposomal Formulation Development Service market?
2. What is the demand of the global Liposomal Formulation Development Service market?
3. What is the year over year growth of the global Liposomal Formulation Development Service market?
4. What is the total value of the global Liposomal Formulation Development Service market?
5. Who are the Major Players in the global Liposomal Formulation Development Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Liposomal Formulation Development Service Introduction
1.2 World Liposomal Formulation Development Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Liposomal Formulation Development Service Total Market by Region (by Headquarter Location)
1.3.1 World Liposomal Formulation Development Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.3 China Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.4 Europe Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.5 Japan Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.6 South Korea Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.8 India Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Liposomal Formulation Development Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Liposomal Formulation Development Service Consumption Value (2021-2032)
2.2 World Liposomal Formulation Development Service Consumption Value by Region
2.2.1 World Liposomal Formulation Development Service Consumption Value by Region (2021-2026)
2.2.2 World Liposomal Formulation Development Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Liposomal Formulation Development Service Consumption Value (2021-2032)
2.4 China Liposomal Formulation Development Service Consumption Value (2021-2032)
2.5 Europe Liposomal Formulation Development Service Consumption Value (2021-2032)
2.6 Japan Liposomal Formulation Development Service Consumption Value (2021-2032)
2.7 South Korea Liposomal Formulation Development Service Consumption Value (2021-2032)
2.8 ASEAN Liposomal Formulation Development Service Consumption Value (2021-2032)
2.9 India Liposomal Formulation Development Service Consumption Value (2021-2032)
3 WORLD LIPOSOMAL FORMULATION DEVELOPMENT SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Liposomal Formulation Development Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Liposomal Formulation Development Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Liposomal Formulation Development Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Liposomal Formulation Development Service in 2025
3.3 Liposomal Formulation Development Service Company Evaluation Quadrant
3.4 Liposomal Formulation Development Service Market: Overall Company Footprint Analysis
3.4.1 Liposomal Formulation Development Service Market: Region Footprint
3.4.2 Liposomal Formulation Development Service Market: Company Product Type Footprint
3.4.3 Liposomal Formulation Development Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Liposomal Formulation Development Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Liposomal Formulation Development Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Liposomal Formulation Development Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Liposomal Formulation Development Service Consumption Value Comparison
4.2.1 United States VS China: Liposomal Formulation Development Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Liposomal Formulation Development Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Liposomal Formulation Development Service Companies and Market Share, 2021-2026
4.3.1 United States Based Liposomal Formulation Development Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Liposomal Formulation Development Service Revenue, (2021-2026)
4.4 China Based Companies Liposomal Formulation Development Service Revenue and Market Share, 2021-2026
4.4.1 China Based Liposomal Formulation Development Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Liposomal Formulation Development Service Revenue, (2021-2026)
4.5 Rest of World Based Liposomal Formulation Development Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Liposomal Formulation Development Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Liposomal Formulation Development Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Liposomal Formulation Development Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 mRNA-Liposomal
5.2.2 siRNA-Liposomal
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Liposomal Formulation Development Service Market Size by Type (2021-2026)
5.3.2 World Liposomal Formulation Development Service Market Size by Type (2027-2032)
5.3.3 World Liposomal Formulation Development Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEVELOPMENT STAGE
6.1 World Liposomal Formulation Development Service Market Size Overview by Development Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Development Stage
6.2.1 Pre-formulation Development
6.2.2 Formulation Screening and Optimization
6.2.3 Analytical Method Development
6.2.4 Process Development
6.2.5 Other
6.3 Market Segment by Development Stage
6.3.1 World Liposomal Formulation Development Service Market Size by Development Stage (2021-2026)
6.3.2 World Liposomal Formulation Development Service Market Size by Development Stage (2027-2032)
6.3.3 World Liposomal Formulation Development Service Market Size Market Share by Development Stage (2027-2032)
7 MARKET ANALYSIS BY ACTIVE PHARMACEUTICAL INGREDIENT
7.1 World Liposomal Formulation Development Service Market Size Overview by Active Pharmaceutical Ingredient: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Active Pharmaceutical Ingredient
7.2.1 Small Molecule Drugs
7.2.2 Peptides and Proteins
7.2.3 Nucleic Acid Therapeutics
7.2.4 Others
7.3 Market Segment by Active Pharmaceutical Ingredient
7.3.1 World Liposomal Formulation Development Service Market Size by Active Pharmaceutical Ingredient (2021-2026)
7.3.2 World Liposomal Formulation Development Service Market Size by Active Pharmaceutical Ingredient (2027-2032)
7.3.3 World Liposomal Formulation Development Service Market Size Market Share by Active Pharmaceutical Ingredient (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Liposomal Formulation Development Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Gene Therapy
8.2.2 Vaccine
8.2.3 Cancer Treatment
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Liposomal Formulation Development Service Market Size by Application (2021-2026)
8.3.2 World Liposomal Formulation Development Service Market Size by Application (2027-2032)
8.3.3 World Liposomal Formulation Development Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Cytiva
9.1.1 Cytiva Details
9.1.2 Cytiva Major Business
9.1.3 Cytiva Liposomal Formulation Development Service Product and Services
9.1.4 Cytiva Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Cytiva Recent Developments/Updates
9.1.6 Cytiva Competitive Strengths & Weaknesses
9.2 Croda International
9.2.1 Croda International Details
9.2.2 Croda International Major Business
9.2.3 Croda International Liposomal Formulation Development Service Product and Services
9.2.4 Croda International Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Croda International Recent Developments/Updates
9.2.6 Croda International Competitive Strengths & Weaknesses
9.3 Evonik
9.3.1 Evonik Details
9.3.2 Evonik Major Business
9.3.3 Evonik Liposomal Formulation Development Service Product and Services
9.3.4 Evonik Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Evonik Recent Developments/Updates
9.3.6 Evonik Competitive Strengths & Weaknesses
9.4 Merck KGaA
9.4.1 Merck KGaA Details
9.4.2 Merck KGaA Major Business
9.4.3 Merck KGaA Liposomal Formulation Development Service Product and Services
9.4.4 Merck KGaA Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Merck KGaA Recent Developments/Updates
9.4.6 Merck KGaA Competitive Strengths & Weaknesses
9.5 Genevant Sciences
9.5.1 Genevant Sciences Details
9.5.2 Genevant Sciences Major Business
9.5.3 Genevant Sciences Liposomal Formulation Development Service Product and Services
9.5.4 Genevant Sciences Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Genevant Sciences Recent Developments/Updates
9.5.6 Genevant Sciences Competitive Strengths & Weaknesses
9.6 Nippon Fine Chemical
9.6.1 Nippon Fine Chemical Details
9.6.2 Nippon Fine Chemical Major Business
9.6.3 Nippon Fine Chemical Liposomal Formulation Development Service Product and Services
9.6.4 Nippon Fine Chemical Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Nippon Fine Chemical Recent Developments/Updates
9.6.6 Nippon Fine Chemical Competitive Strengths & Weaknesses
9.7 Polymun Scientific
9.7.1 Polymun Scientific Details
9.7.2 Polymun Scientific Major Business
9.7.3 Polymun Scientific Liposomal Formulation Development Service Product and Services
9.7.4 Polymun Scientific Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Polymun Scientific Recent Developments/Updates
9.7.6 Polymun Scientific Competitive Strengths & Weaknesses
9.8 Corden Pharma
9.8.1 Corden Pharma Details
9.8.2 Corden Pharma Major Business
9.8.3 Corden Pharma Liposomal Formulation Development Service Product and Services
9.8.4 Corden Pharma Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Corden Pharma Recent Developments/Updates
9.8.6 Corden Pharma Competitive Strengths & Weaknesses
9.9 Acuitas Therapeutics
9.9.1 Acuitas Therapeutics Details
9.9.2 Acuitas Therapeutics Major Business
9.9.3 Acuitas Therapeutics Liposomal Formulation Development Service Product and Services
9.9.4 Acuitas Therapeutics Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Acuitas Therapeutics Recent Developments/Updates
9.9.6 Acuitas Therapeutics Competitive Strengths & Weaknesses
9.10 Creative Biolabs
9.10.1 Creative Biolabs Details
9.10.2 Creative Biolabs Major Business
9.10.3 Creative Biolabs Liposomal Formulation Development Service Product and Services
9.10.4 Creative Biolabs Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Creative Biolabs Recent Developments/Updates
9.10.6 Creative Biolabs Competitive Strengths & Weaknesses
9.11 GenScript
9.11.1 GenScript Details
9.11.2 GenScript Major Business
9.11.3 GenScript Liposomal Formulation Development Service Product and Services
9.11.4 GenScript Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 GenScript Recent Developments/Updates
9.11.6 GenScript Competitive Strengths & Weaknesses
9.12 WuXi STA
9.12.1 WuXi STA Details
9.12.2 WuXi STA Major Business
9.12.3 WuXi STA Liposomal Formulation Development Service Product and Services
9.12.4 WuXi STA Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 WuXi STA Recent Developments/Updates
9.12.6 WuXi STA Competitive Strengths & Weaknesses
9.13 MicroNano Biologics
9.13.1 MicroNano Biologics Details
9.13.2 MicroNano Biologics Major Business
9.13.3 MicroNano Biologics Liposomal Formulation Development Service Product and Services
9.13.4 MicroNano Biologics Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 MicroNano Biologics Recent Developments/Updates
9.13.6 MicroNano Biologics Competitive Strengths & Weaknesses
9.14 Precigenome
9.14.1 Precigenome Details
9.14.2 Precigenome Major Business
9.14.3 Precigenome Liposomal Formulation Development Service Product and Services
9.14.4 Precigenome Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Precigenome Recent Developments/Updates
9.14.6 Precigenome Competitive Strengths & Weaknesses
9.15 Catalent
9.15.1 Catalent Details
9.15.2 Catalent Major Business
9.15.3 Catalent Liposomal Formulation Development Service Product and Services
9.15.4 Catalent Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Catalent Recent Developments/Updates
9.15.6 Catalent Competitive Strengths & Weaknesses
9.16 Wacker
9.16.1 Wacker Details
9.16.2 Wacker Major Business
9.16.3 Wacker Liposomal Formulation Development Service Product and Services
9.16.4 Wacker Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Wacker Recent Developments/Updates
9.16.6 Wacker Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Liposomal Formulation Development Service Industry Chain
10.2 Liposomal Formulation Development Service Upstream Analysis
10.3 Liposomal Formulation Development Service Midstream Analysis
10.4 Liposomal Formulation Development Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Liposomal Formulation Development Service Introduction
1.2 World Liposomal Formulation Development Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Liposomal Formulation Development Service Total Market by Region (by Headquarter Location)
1.3.1 World Liposomal Formulation Development Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.3 China Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.4 Europe Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.5 Japan Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.6 South Korea Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.3.8 India Based Company Liposomal Formulation Development Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Liposomal Formulation Development Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Liposomal Formulation Development Service Consumption Value (2021-2032)
2.2 World Liposomal Formulation Development Service Consumption Value by Region
2.2.1 World Liposomal Formulation Development Service Consumption Value by Region (2021-2026)
2.2.2 World Liposomal Formulation Development Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Liposomal Formulation Development Service Consumption Value (2021-2032)
2.4 China Liposomal Formulation Development Service Consumption Value (2021-2032)
2.5 Europe Liposomal Formulation Development Service Consumption Value (2021-2032)
2.6 Japan Liposomal Formulation Development Service Consumption Value (2021-2032)
2.7 South Korea Liposomal Formulation Development Service Consumption Value (2021-2032)
2.8 ASEAN Liposomal Formulation Development Service Consumption Value (2021-2032)
2.9 India Liposomal Formulation Development Service Consumption Value (2021-2032)
3 WORLD LIPOSOMAL FORMULATION DEVELOPMENT SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Liposomal Formulation Development Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Liposomal Formulation Development Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Liposomal Formulation Development Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Liposomal Formulation Development Service in 2025
3.3 Liposomal Formulation Development Service Company Evaluation Quadrant
3.4 Liposomal Formulation Development Service Market: Overall Company Footprint Analysis
3.4.1 Liposomal Formulation Development Service Market: Region Footprint
3.4.2 Liposomal Formulation Development Service Market: Company Product Type Footprint
3.4.3 Liposomal Formulation Development Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Liposomal Formulation Development Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Liposomal Formulation Development Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Liposomal Formulation Development Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Liposomal Formulation Development Service Consumption Value Comparison
4.2.1 United States VS China: Liposomal Formulation Development Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Liposomal Formulation Development Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Liposomal Formulation Development Service Companies and Market Share, 2021-2026
4.3.1 United States Based Liposomal Formulation Development Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Liposomal Formulation Development Service Revenue, (2021-2026)
4.4 China Based Companies Liposomal Formulation Development Service Revenue and Market Share, 2021-2026
4.4.1 China Based Liposomal Formulation Development Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Liposomal Formulation Development Service Revenue, (2021-2026)
4.5 Rest of World Based Liposomal Formulation Development Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Liposomal Formulation Development Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Liposomal Formulation Development Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Liposomal Formulation Development Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 mRNA-Liposomal
5.2.2 siRNA-Liposomal
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Liposomal Formulation Development Service Market Size by Type (2021-2026)
5.3.2 World Liposomal Formulation Development Service Market Size by Type (2027-2032)
5.3.3 World Liposomal Formulation Development Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY DEVELOPMENT STAGE
6.1 World Liposomal Formulation Development Service Market Size Overview by Development Stage: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Development Stage
6.2.1 Pre-formulation Development
6.2.2 Formulation Screening and Optimization
6.2.3 Analytical Method Development
6.2.4 Process Development
6.2.5 Other
6.3 Market Segment by Development Stage
6.3.1 World Liposomal Formulation Development Service Market Size by Development Stage (2021-2026)
6.3.2 World Liposomal Formulation Development Service Market Size by Development Stage (2027-2032)
6.3.3 World Liposomal Formulation Development Service Market Size Market Share by Development Stage (2027-2032)
7 MARKET ANALYSIS BY ACTIVE PHARMACEUTICAL INGREDIENT
7.1 World Liposomal Formulation Development Service Market Size Overview by Active Pharmaceutical Ingredient: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Active Pharmaceutical Ingredient
7.2.1 Small Molecule Drugs
7.2.2 Peptides and Proteins
7.2.3 Nucleic Acid Therapeutics
7.2.4 Others
7.3 Market Segment by Active Pharmaceutical Ingredient
7.3.1 World Liposomal Formulation Development Service Market Size by Active Pharmaceutical Ingredient (2021-2026)
7.3.2 World Liposomal Formulation Development Service Market Size by Active Pharmaceutical Ingredient (2027-2032)
7.3.3 World Liposomal Formulation Development Service Market Size Market Share by Active Pharmaceutical Ingredient (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Liposomal Formulation Development Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Gene Therapy
8.2.2 Vaccine
8.2.3 Cancer Treatment
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Liposomal Formulation Development Service Market Size by Application (2021-2026)
8.3.2 World Liposomal Formulation Development Service Market Size by Application (2027-2032)
8.3.3 World Liposomal Formulation Development Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Cytiva
9.1.1 Cytiva Details
9.1.2 Cytiva Major Business
9.1.3 Cytiva Liposomal Formulation Development Service Product and Services
9.1.4 Cytiva Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Cytiva Recent Developments/Updates
9.1.6 Cytiva Competitive Strengths & Weaknesses
9.2 Croda International
9.2.1 Croda International Details
9.2.2 Croda International Major Business
9.2.3 Croda International Liposomal Formulation Development Service Product and Services
9.2.4 Croda International Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Croda International Recent Developments/Updates
9.2.6 Croda International Competitive Strengths & Weaknesses
9.3 Evonik
9.3.1 Evonik Details
9.3.2 Evonik Major Business
9.3.3 Evonik Liposomal Formulation Development Service Product and Services
9.3.4 Evonik Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Evonik Recent Developments/Updates
9.3.6 Evonik Competitive Strengths & Weaknesses
9.4 Merck KGaA
9.4.1 Merck KGaA Details
9.4.2 Merck KGaA Major Business
9.4.3 Merck KGaA Liposomal Formulation Development Service Product and Services
9.4.4 Merck KGaA Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Merck KGaA Recent Developments/Updates
9.4.6 Merck KGaA Competitive Strengths & Weaknesses
9.5 Genevant Sciences
9.5.1 Genevant Sciences Details
9.5.2 Genevant Sciences Major Business
9.5.3 Genevant Sciences Liposomal Formulation Development Service Product and Services
9.5.4 Genevant Sciences Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Genevant Sciences Recent Developments/Updates
9.5.6 Genevant Sciences Competitive Strengths & Weaknesses
9.6 Nippon Fine Chemical
9.6.1 Nippon Fine Chemical Details
9.6.2 Nippon Fine Chemical Major Business
9.6.3 Nippon Fine Chemical Liposomal Formulation Development Service Product and Services
9.6.4 Nippon Fine Chemical Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Nippon Fine Chemical Recent Developments/Updates
9.6.6 Nippon Fine Chemical Competitive Strengths & Weaknesses
9.7 Polymun Scientific
9.7.1 Polymun Scientific Details
9.7.2 Polymun Scientific Major Business
9.7.3 Polymun Scientific Liposomal Formulation Development Service Product and Services
9.7.4 Polymun Scientific Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Polymun Scientific Recent Developments/Updates
9.7.6 Polymun Scientific Competitive Strengths & Weaknesses
9.8 Corden Pharma
9.8.1 Corden Pharma Details
9.8.2 Corden Pharma Major Business
9.8.3 Corden Pharma Liposomal Formulation Development Service Product and Services
9.8.4 Corden Pharma Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Corden Pharma Recent Developments/Updates
9.8.6 Corden Pharma Competitive Strengths & Weaknesses
9.9 Acuitas Therapeutics
9.9.1 Acuitas Therapeutics Details
9.9.2 Acuitas Therapeutics Major Business
9.9.3 Acuitas Therapeutics Liposomal Formulation Development Service Product and Services
9.9.4 Acuitas Therapeutics Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Acuitas Therapeutics Recent Developments/Updates
9.9.6 Acuitas Therapeutics Competitive Strengths & Weaknesses
9.10 Creative Biolabs
9.10.1 Creative Biolabs Details
9.10.2 Creative Biolabs Major Business
9.10.3 Creative Biolabs Liposomal Formulation Development Service Product and Services
9.10.4 Creative Biolabs Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Creative Biolabs Recent Developments/Updates
9.10.6 Creative Biolabs Competitive Strengths & Weaknesses
9.11 GenScript
9.11.1 GenScript Details
9.11.2 GenScript Major Business
9.11.3 GenScript Liposomal Formulation Development Service Product and Services
9.11.4 GenScript Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 GenScript Recent Developments/Updates
9.11.6 GenScript Competitive Strengths & Weaknesses
9.12 WuXi STA
9.12.1 WuXi STA Details
9.12.2 WuXi STA Major Business
9.12.3 WuXi STA Liposomal Formulation Development Service Product and Services
9.12.4 WuXi STA Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 WuXi STA Recent Developments/Updates
9.12.6 WuXi STA Competitive Strengths & Weaknesses
9.13 MicroNano Biologics
9.13.1 MicroNano Biologics Details
9.13.2 MicroNano Biologics Major Business
9.13.3 MicroNano Biologics Liposomal Formulation Development Service Product and Services
9.13.4 MicroNano Biologics Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 MicroNano Biologics Recent Developments/Updates
9.13.6 MicroNano Biologics Competitive Strengths & Weaknesses
9.14 Precigenome
9.14.1 Precigenome Details
9.14.2 Precigenome Major Business
9.14.3 Precigenome Liposomal Formulation Development Service Product and Services
9.14.4 Precigenome Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Precigenome Recent Developments/Updates
9.14.6 Precigenome Competitive Strengths & Weaknesses
9.15 Catalent
9.15.1 Catalent Details
9.15.2 Catalent Major Business
9.15.3 Catalent Liposomal Formulation Development Service Product and Services
9.15.4 Catalent Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Catalent Recent Developments/Updates
9.15.6 Catalent Competitive Strengths & Weaknesses
9.16 Wacker
9.16.1 Wacker Details
9.16.2 Wacker Major Business
9.16.3 Wacker Liposomal Formulation Development Service Product and Services
9.16.4 Wacker Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Wacker Recent Developments/Updates
9.16.6 Wacker Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Liposomal Formulation Development Service Industry Chain
10.2 Liposomal Formulation Development Service Upstream Analysis
10.3 Liposomal Formulation Development Service Midstream Analysis
10.4 Liposomal Formulation Development Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Liposomal Formulation Development Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Liposomal Formulation Development Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Liposomal Formulation Development Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Liposomal Formulation Development Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Liposomal Formulation Development Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Liposomal Formulation Development Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Liposomal Formulation Development Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Liposomal Formulation Development Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Liposomal Formulation Development Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Liposomal Formulation Development Service Players in 2025
Table 12. World Liposomal Formulation Development Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Liposomal Formulation Development Service Company Evaluation Quadrant
Table 14. Head Office of Key Liposomal Formulation Development Service Players
Table 15. Liposomal Formulation Development Service Market: Company Product Type Footprint
Table 16. Liposomal Formulation Development Service Market: Company Product Application Footprint
Table 17. Liposomal Formulation Development Service Mergers & Acquisitions Activity
Table 18. United States VS China Liposomal Formulation Development Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Liposomal Formulation Development Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Liposomal Formulation Development Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Liposomal Formulation Development Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Liposomal Formulation Development Service Revenue Market Share (2021-2026)
Table 23. China Based Liposomal Formulation Development Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Liposomal Formulation Development Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Liposomal Formulation Development Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Liposomal Formulation Development Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Liposomal Formulation Development Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Liposomal Formulation Development Service Revenue Market Share (2021-2026)
Table 29. World Liposomal Formulation Development Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Liposomal Formulation Development Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Liposomal Formulation Development Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Liposomal Formulation Development Service Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World Liposomal Formulation Development Service Market Size Value by Development Stage (2021-2026) & (USD Million)
Table 34. World Liposomal Formulation Development Service Market Size by Development Stage (2027-2032) & (USD Million)
Table 35. World Liposomal Formulation Development Service Market Size by Active Pharmaceutical Ingredient, (USD Million), 2021 & 2025 & 2032
Table 36. World Liposomal Formulation Development Service Market Size Value by Active Pharmaceutical Ingredient (2021-2026) & (USD Million)
Table 37. World Liposomal Formulation Development Service Market Size by Active Pharmaceutical Ingredient (2027-2032) & (USD Million)
Table 38. World Liposomal Formulation Development Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Liposomal Formulation Development Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Liposomal Formulation Development Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Cytiva Basic Information, Manufacturing Base and Competitors
Table 42. Cytiva Major Business
Table 43. Cytiva Liposomal Formulation Development Service Product and Services
Table 44. Cytiva Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Cytiva Recent Developments/Updates
Table 46. Cytiva Competitive Strengths & Weaknesses
Table 47. Croda International Basic Information, Manufacturing Base and Competitors
Table 48. Croda International Major Business
Table 49. Croda International Liposomal Formulation Development Service Product and Services
Table 50. Croda International Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Croda International Recent Developments/Updates
Table 52. Croda International Competitive Strengths & Weaknesses
Table 53. Evonik Basic Information, Manufacturing Base and Competitors
Table 54. Evonik Major Business
Table 55. Evonik Liposomal Formulation Development Service Product and Services
Table 56. Evonik Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Evonik Recent Developments/Updates
Table 58. Evonik Competitive Strengths & Weaknesses
Table 59. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 60. Merck KGaA Major Business
Table 61. Merck KGaA Liposomal Formulation Development Service Product and Services
Table 62. Merck KGaA Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Merck KGaA Recent Developments/Updates
Table 64. Merck KGaA Competitive Strengths & Weaknesses
Table 65. Genevant Sciences Basic Information, Manufacturing Base and Competitors
Table 66. Genevant Sciences Major Business
Table 67. Genevant Sciences Liposomal Formulation Development Service Product and Services
Table 68. Genevant Sciences Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Genevant Sciences Recent Developments/Updates
Table 70. Genevant Sciences Competitive Strengths & Weaknesses
Table 71. Nippon Fine Chemical Basic Information, Manufacturing Base and Competitors
Table 72. Nippon Fine Chemical Major Business
Table 73. Nippon Fine Chemical Liposomal Formulation Development Service Product and Services
Table 74. Nippon Fine Chemical Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Nippon Fine Chemical Recent Developments/Updates
Table 76. Nippon Fine Chemical Competitive Strengths & Weaknesses
Table 77. Polymun Scientific Basic Information, Manufacturing Base and Competitors
Table 78. Polymun Scientific Major Business
Table 79. Polymun Scientific Liposomal Formulation Development Service Product and Services
Table 80. Polymun Scientific Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Polymun Scientific Recent Developments/Updates
Table 82. Polymun Scientific Competitive Strengths & Weaknesses
Table 83. Corden Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Corden Pharma Major Business
Table 85. Corden Pharma Liposomal Formulation Development Service Product and Services
Table 86. Corden Pharma Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Corden Pharma Recent Developments/Updates
Table 88. Corden Pharma Competitive Strengths & Weaknesses
Table 89. Acuitas Therapeutics Basic Information, Manufacturing Base and Competitors
Table 90. Acuitas Therapeutics Major Business
Table 91. Acuitas Therapeutics Liposomal Formulation Development Service Product and Services
Table 92. Acuitas Therapeutics Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Acuitas Therapeutics Recent Developments/Updates
Table 94. Acuitas Therapeutics Competitive Strengths & Weaknesses
Table 95. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 96. Creative Biolabs Major Business
Table 97. Creative Biolabs Liposomal Formulation Development Service Product and Services
Table 98. Creative Biolabs Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Creative Biolabs Recent Developments/Updates
Table 100. Creative Biolabs Competitive Strengths & Weaknesses
Table 101. GenScript Basic Information, Manufacturing Base and Competitors
Table 102. GenScript Major Business
Table 103. GenScript Liposomal Formulation Development Service Product and Services
Table 104. GenScript Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. GenScript Recent Developments/Updates
Table 106. GenScript Competitive Strengths & Weaknesses
Table 107. WuXi STA Basic Information, Manufacturing Base and Competitors
Table 108. WuXi STA Major Business
Table 109. WuXi STA Liposomal Formulation Development Service Product and Services
Table 110. WuXi STA Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. WuXi STA Recent Developments/Updates
Table 112. WuXi STA Competitive Strengths & Weaknesses
Table 113. MicroNano Biologics Basic Information, Manufacturing Base and Competitors
Table 114. MicroNano Biologics Major Business
Table 115. MicroNano Biologics Liposomal Formulation Development Service Product and Services
Table 116. MicroNano Biologics Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. MicroNano Biologics Recent Developments/Updates
Table 118. MicroNano Biologics Competitive Strengths & Weaknesses
Table 119. Precigenome Basic Information, Manufacturing Base and Competitors
Table 120. Precigenome Major Business
Table 121. Precigenome Liposomal Formulation Development Service Product and Services
Table 122. Precigenome Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Precigenome Recent Developments/Updates
Table 124. Precigenome Competitive Strengths & Weaknesses
Table 125. Catalent Basic Information, Manufacturing Base and Competitors
Table 126. Catalent Major Business
Table 127. Catalent Liposomal Formulation Development Service Product and Services
Table 128. Catalent Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Catalent Recent Developments/Updates
Table 130. Catalent Competitive Strengths & Weaknesses
Table 131. Wacker Basic Information, Manufacturing Base and Competitors
Table 132. Wacker Major Business
Table 133. Wacker Liposomal Formulation Development Service Product and Services
Table 134. Wacker Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Wacker Recent Developments/Updates
Table 136. Wacker Competitive Strengths & Weaknesses
Table 137. Global Key Players of Liposomal Formulation Development Service Upstream (Raw Materials)
Table 138. Global Liposomal Formulation Development Service Typical Customers
Table 1. World Liposomal Formulation Development Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Liposomal Formulation Development Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Liposomal Formulation Development Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Liposomal Formulation Development Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Liposomal Formulation Development Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Liposomal Formulation Development Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Liposomal Formulation Development Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Liposomal Formulation Development Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Liposomal Formulation Development Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Liposomal Formulation Development Service Players in 2025
Table 12. World Liposomal Formulation Development Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Liposomal Formulation Development Service Company Evaluation Quadrant
Table 14. Head Office of Key Liposomal Formulation Development Service Players
Table 15. Liposomal Formulation Development Service Market: Company Product Type Footprint
Table 16. Liposomal Formulation Development Service Market: Company Product Application Footprint
Table 17. Liposomal Formulation Development Service Mergers & Acquisitions Activity
Table 18. United States VS China Liposomal Formulation Development Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Liposomal Formulation Development Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Liposomal Formulation Development Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Liposomal Formulation Development Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Liposomal Formulation Development Service Revenue Market Share (2021-2026)
Table 23. China Based Liposomal Formulation Development Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Liposomal Formulation Development Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Liposomal Formulation Development Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Liposomal Formulation Development Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Liposomal Formulation Development Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Liposomal Formulation Development Service Revenue Market Share (2021-2026)
Table 29. World Liposomal Formulation Development Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Liposomal Formulation Development Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Liposomal Formulation Development Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Liposomal Formulation Development Service Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Table 33. World Liposomal Formulation Development Service Market Size Value by Development Stage (2021-2026) & (USD Million)
Table 34. World Liposomal Formulation Development Service Market Size by Development Stage (2027-2032) & (USD Million)
Table 35. World Liposomal Formulation Development Service Market Size by Active Pharmaceutical Ingredient, (USD Million), 2021 & 2025 & 2032
Table 36. World Liposomal Formulation Development Service Market Size Value by Active Pharmaceutical Ingredient (2021-2026) & (USD Million)
Table 37. World Liposomal Formulation Development Service Market Size by Active Pharmaceutical Ingredient (2027-2032) & (USD Million)
Table 38. World Liposomal Formulation Development Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Liposomal Formulation Development Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Liposomal Formulation Development Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Cytiva Basic Information, Manufacturing Base and Competitors
Table 42. Cytiva Major Business
Table 43. Cytiva Liposomal Formulation Development Service Product and Services
Table 44. Cytiva Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Cytiva Recent Developments/Updates
Table 46. Cytiva Competitive Strengths & Weaknesses
Table 47. Croda International Basic Information, Manufacturing Base and Competitors
Table 48. Croda International Major Business
Table 49. Croda International Liposomal Formulation Development Service Product and Services
Table 50. Croda International Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Croda International Recent Developments/Updates
Table 52. Croda International Competitive Strengths & Weaknesses
Table 53. Evonik Basic Information, Manufacturing Base and Competitors
Table 54. Evonik Major Business
Table 55. Evonik Liposomal Formulation Development Service Product and Services
Table 56. Evonik Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Evonik Recent Developments/Updates
Table 58. Evonik Competitive Strengths & Weaknesses
Table 59. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 60. Merck KGaA Major Business
Table 61. Merck KGaA Liposomal Formulation Development Service Product and Services
Table 62. Merck KGaA Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Merck KGaA Recent Developments/Updates
Table 64. Merck KGaA Competitive Strengths & Weaknesses
Table 65. Genevant Sciences Basic Information, Manufacturing Base and Competitors
Table 66. Genevant Sciences Major Business
Table 67. Genevant Sciences Liposomal Formulation Development Service Product and Services
Table 68. Genevant Sciences Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Genevant Sciences Recent Developments/Updates
Table 70. Genevant Sciences Competitive Strengths & Weaknesses
Table 71. Nippon Fine Chemical Basic Information, Manufacturing Base and Competitors
Table 72. Nippon Fine Chemical Major Business
Table 73. Nippon Fine Chemical Liposomal Formulation Development Service Product and Services
Table 74. Nippon Fine Chemical Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Nippon Fine Chemical Recent Developments/Updates
Table 76. Nippon Fine Chemical Competitive Strengths & Weaknesses
Table 77. Polymun Scientific Basic Information, Manufacturing Base and Competitors
Table 78. Polymun Scientific Major Business
Table 79. Polymun Scientific Liposomal Formulation Development Service Product and Services
Table 80. Polymun Scientific Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Polymun Scientific Recent Developments/Updates
Table 82. Polymun Scientific Competitive Strengths & Weaknesses
Table 83. Corden Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Corden Pharma Major Business
Table 85. Corden Pharma Liposomal Formulation Development Service Product and Services
Table 86. Corden Pharma Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Corden Pharma Recent Developments/Updates
Table 88. Corden Pharma Competitive Strengths & Weaknesses
Table 89. Acuitas Therapeutics Basic Information, Manufacturing Base and Competitors
Table 90. Acuitas Therapeutics Major Business
Table 91. Acuitas Therapeutics Liposomal Formulation Development Service Product and Services
Table 92. Acuitas Therapeutics Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Acuitas Therapeutics Recent Developments/Updates
Table 94. Acuitas Therapeutics Competitive Strengths & Weaknesses
Table 95. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 96. Creative Biolabs Major Business
Table 97. Creative Biolabs Liposomal Formulation Development Service Product and Services
Table 98. Creative Biolabs Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Creative Biolabs Recent Developments/Updates
Table 100. Creative Biolabs Competitive Strengths & Weaknesses
Table 101. GenScript Basic Information, Manufacturing Base and Competitors
Table 102. GenScript Major Business
Table 103. GenScript Liposomal Formulation Development Service Product and Services
Table 104. GenScript Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. GenScript Recent Developments/Updates
Table 106. GenScript Competitive Strengths & Weaknesses
Table 107. WuXi STA Basic Information, Manufacturing Base and Competitors
Table 108. WuXi STA Major Business
Table 109. WuXi STA Liposomal Formulation Development Service Product and Services
Table 110. WuXi STA Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. WuXi STA Recent Developments/Updates
Table 112. WuXi STA Competitive Strengths & Weaknesses
Table 113. MicroNano Biologics Basic Information, Manufacturing Base and Competitors
Table 114. MicroNano Biologics Major Business
Table 115. MicroNano Biologics Liposomal Formulation Development Service Product and Services
Table 116. MicroNano Biologics Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. MicroNano Biologics Recent Developments/Updates
Table 118. MicroNano Biologics Competitive Strengths & Weaknesses
Table 119. Precigenome Basic Information, Manufacturing Base and Competitors
Table 120. Precigenome Major Business
Table 121. Precigenome Liposomal Formulation Development Service Product and Services
Table 122. Precigenome Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Precigenome Recent Developments/Updates
Table 124. Precigenome Competitive Strengths & Weaknesses
Table 125. Catalent Basic Information, Manufacturing Base and Competitors
Table 126. Catalent Major Business
Table 127. Catalent Liposomal Formulation Development Service Product and Services
Table 128. Catalent Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Catalent Recent Developments/Updates
Table 130. Catalent Competitive Strengths & Weaknesses
Table 131. Wacker Basic Information, Manufacturing Base and Competitors
Table 132. Wacker Major Business
Table 133. Wacker Liposomal Formulation Development Service Product and Services
Table 134. Wacker Liposomal Formulation Development Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Wacker Recent Developments/Updates
Table 136. Wacker Competitive Strengths & Weaknesses
Table 137. Global Key Players of Liposomal Formulation Development Service Upstream (Raw Materials)
Table 138. Global Liposomal Formulation Development Service Typical Customers
LIST OF FIGURES
Figure 1. Liposomal Formulation Development Service Picture
Figure 2. World Liposomal Formulation Development Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Liposomal Formulation Development Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Liposomal Formulation Development Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Liposomal Formulation Development Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 13. Liposomal Formulation Development Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Liposomal Formulation Development Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Liposomal Formulation Development Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Liposomal Formulation Development Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Liposomal Formulation Development Service Markets in 2025
Figure 27. United States VS China: Liposomal Formulation Development Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Liposomal Formulation Development Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Liposomal Formulation Development Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Liposomal Formulation Development Service Market Size Market Share by Type in 2025
Figure 31. mRNA-Liposomal
Figure 32. siRNA-Liposomal
Figure 33. Other
Figure 34. World Liposomal Formulation Development Service Market Size Market Share by Type (2021-2032)
Figure 35. World Liposomal Formulation Development Service Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 36. World Liposomal Formulation Development Service Market Size Market Share by Development Stage in 2025
Figure 37. Pre-formulation Development
Figure 38. Formulation Screening and Optimization
Figure 39. Analytical Method Development
Figure 40. Process Development
Figure 41. Other
Figure 42. World Liposomal Formulation Development Service Market Size Market Share by Development Stage (2021-2032)
Figure 43. World Liposomal Formulation Development Service Market Size by Active Pharmaceutical Ingredient, (USD Million), 2021 & 2025 & 2032
Figure 44. World Liposomal Formulation Development Service Market Size Market Share by Active Pharmaceutical Ingredient in 2025
Figure 45. Small Molecule Drugs
Figure 46. Peptides and Proteins
Figure 47. Nucleic Acid Therapeutics
Figure 48. Others
Figure 49. World Liposomal Formulation Development Service Market Size Market Share by Active Pharmaceutical Ingredient (2021-2032)
Figure 50. World Liposomal Formulation Development Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Liposomal Formulation Development Service Market Size Market Share by Application in 2025
Figure 52. Gene Therapy
Figure 53. Vaccine
Figure 54. Cancer Treatment
Figure 55. Others
Figure 56. World Liposomal Formulation Development Service Market Size Market Share by Application (2021-2032)
Figure 57. Liposomal Formulation Development Service Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
Figure 1. Liposomal Formulation Development Service Picture
Figure 2. World Liposomal Formulation Development Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Liposomal Formulation Development Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Liposomal Formulation Development Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Liposomal Formulation Development Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Liposomal Formulation Development Service Revenue (2021-2032) & (USD Million)
Figure 13. Liposomal Formulation Development Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Liposomal Formulation Development Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Liposomal Formulation Development Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Liposomal Formulation Development Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Liposomal Formulation Development Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Liposomal Formulation Development Service Markets in 2025
Figure 27. United States VS China: Liposomal Formulation Development Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Liposomal Formulation Development Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Liposomal Formulation Development Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Liposomal Formulation Development Service Market Size Market Share by Type in 2025
Figure 31. mRNA-Liposomal
Figure 32. siRNA-Liposomal
Figure 33. Other
Figure 34. World Liposomal Formulation Development Service Market Size Market Share by Type (2021-2032)
Figure 35. World Liposomal Formulation Development Service Market Size by Development Stage, (USD Million), 2021 & 2025 & 2032
Figure 36. World Liposomal Formulation Development Service Market Size Market Share by Development Stage in 2025
Figure 37. Pre-formulation Development
Figure 38. Formulation Screening and Optimization
Figure 39. Analytical Method Development
Figure 40. Process Development
Figure 41. Other
Figure 42. World Liposomal Formulation Development Service Market Size Market Share by Development Stage (2021-2032)
Figure 43. World Liposomal Formulation Development Service Market Size by Active Pharmaceutical Ingredient, (USD Million), 2021 & 2025 & 2032
Figure 44. World Liposomal Formulation Development Service Market Size Market Share by Active Pharmaceutical Ingredient in 2025
Figure 45. Small Molecule Drugs
Figure 46. Peptides and Proteins
Figure 47. Nucleic Acid Therapeutics
Figure 48. Others
Figure 49. World Liposomal Formulation Development Service Market Size Market Share by Active Pharmaceutical Ingredient (2021-2032)
Figure 50. World Liposomal Formulation Development Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Liposomal Formulation Development Service Market Size Market Share by Application in 2025
Figure 52. Gene Therapy
Figure 53. Vaccine
Figure 54. Cancer Treatment
Figure 55. Others
Figure 56. World Liposomal Formulation Development Service Market Size Market Share by Application (2021-2032)
Figure 57. Liposomal Formulation Development Service Industrial Chain
Figure 58. Methodology
Figure 59. Research Process and Data Source
